(CYTK:Consolidated Issue listed on NASDAQ Capital Market)
Earnings & Estimates Summary - CYTOKINETICS INC (CYTK)
2012 revenues at Cytokinetics, Incorporated totaled $7.6M USD, while annual losses equaled $2.22 per share.
Quarterly Earnings & Estimates - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Quarterly Earnings
Cytokinetics, Incorporated reported 3rd quarter 2013 losses of $0.43 per share on 11/1/2013.
Annual Earnings & Estimates - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Annual Earnings
Cytokinetics, Incorporated reported annual 2012 losses of $2.22 per share on 02/7/2013.
Quarterly Revenues - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Quarterly Revenues
Cytokinetics, Incorporated had 3rd quarter 2013 revenues of $4.5M USD. This missed the $17.0M USD consensus estimate of the 7 analysts following the company. This was 160.7% above the prior year's 3rd quarter results.
Annual Revenues - CYTOKINETICS INC (CYTK)
Cytokinetics, Incorporated's Annual Revenues
Cytokinetics, Incorporated had revenues for the full year 2012 of $7.6M USD. This was 89.0% above the prior year's results.
|Arqule Inc||$2.07 USD||-0.11|
|Cell Therapeutics Inc||$1.77 USD||-0.05|
|Curis Inc||$2.77 USD||-0.02|
|GlaxoSmithKline SAE||£18.00 EGP||+0.10|
|Infinity Pharmaceuticals Inc||$14.95 USD||-0.39|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26